Recent advances in therapies for eating disorders. Review uri icon

Overview

abstract

  • Eating disorders are serious psychiatric illnesses with high rates of morbidity and mortality. Effective treatments have traditionally included behaviorally focused therapies as well as several medication strategies. Recent years have seen promising developments in these treatments, including additional support for family-based approaches for children and adolescents, new evidence for "third-wave" behavioral therapies, and new support for the use of lisdexamfetamine for binge eating disorder and olanzapine for anorexia nervosa. Case study and pilot data are beginning to show limited support for neuromodulatory interventions targeting brain regions thought to be involved in eating disorders. This review summarizes treatment developments over the last several years and points towards future directions for the field.

publication date

  • September 26, 2019

Research

keywords

  • Anorexia Nervosa
  • Binge-Eating Disorder
  • Feeding and Eating Disorders

Identity

PubMed Central ID

  • PMC6764116

Scopus Document Identifier

  • 85073118254

Digital Object Identifier (DOI)

  • 10.1002/erv.2256

PubMed ID

  • 31598212

Additional Document Info

volume

  • 8